Literature DB >> 32200854

Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function.

Erik J M van Bommel1, Yuliya Lytvyn2, Bruce A Perkins3, Nima Soleymanlou4, Nora M Fagan5, Audrey Koitka-Weber6, Jaap A Joles7, David Z I Cherney2, Daniël H van Raalte8.   

Abstract

Entities:  

Keywords:  SGLT2 inhibition; diabetes; diabetic nephropathy; glomerular hyperfiltration

Mesh：

Substances：

Year:  2020        PMID： 32200854     DOI： 10.1016/j.kint.2019.12.021

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  8 in total

Review 1.  Emerging roles of Sodium-glucose cotransporter 2 inhibitors in Diabetic kidney disease.

Authors:  Tian Gan; Yi Song; Feng Guo; Guijun Qin
Journal:  Mol Biol Rep       Date:  2022-08-24       Impact factor: 2.742

Review 2.  SGLT2is and Renal Protection: From Biological Mechanisms to Real-World Clinical Benefits.

Authors:  Giovanna Leoncini; Elisa Russo; Elisabetta Bussalino; Cecilia Barnini; Francesca Viazzi; Roberto Pontremoli
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 3.  Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors.

Authors:  Rosalie A Scholtes; Michaël J B van Baar; Megan D Kok; Petter Bjornstad; David Z I Cherney; Jaap A Joles; Daniël H van Raalte
Journal:  Nephrology (Carlton)       Date:  2021-01-04       Impact factor: 2.506

Review 4.  Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease.

Authors:  Julio M Martinez-Moreno; Miguel Fontecha-Barriuso; Diego Martin-Sanchez; Juan Guerrero-Mauvecin; Elena Goma-Garces; Beatriz Fernandez-Fernandez; Sol Carriazo; Maria D Sanchez-Niño; Adrian M Ramos; Marta Ruiz-Ortega; Alberto Ortiz; Ana B Sanz
Journal:  Int J Mol Sci       Date:  2020-06-09       Impact factor: 5.923

Review 5.  Cardiorenal Protection in Diabetic Kidney Disease.

Authors:  Jason F Lee; Ecaterina Berzan; Vikas S Sridhar; Ayodele Odutayo; David Z I Cherney
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-19

6.  Influence of Self-Practice Oriented Teaching plus Psychological Intervention on Blood Glucose Level and Psychological State in Patients with Type 2 Diabetes Mellitus on Insulin Therapy.

Authors:  Xuefang Li; Juan Ge; Lei He
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-08       Impact factor: 2.650

7.  Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF.

Authors:  Pardeep S Jhund; Scott D Solomon; Kieran F Docherty; Hiddo J L Heerspink; Inder S Anand; Michael Böhm; Vijay Chopra; Rudolf A de Boer; Akshay S Desai; Junbo Ge; Masafumi Kitakaze; Bela Merkley; Eileen O'Meara; Morten Shou; Sergey Tereshchenko; Subodh Verma; Pham Nguyen Vinh; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Olof Bengtsson; Anna Maria Langkilde; Mikaela Sjöstrand; John J V McMurray
Journal:  Circulation       Date:  2020-10-12       Impact factor: 29.690

Review 8.  The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?

Authors:  Jiang Liu; Jiang Tian; Komal Sodhi; Joseph I Shapiro
Journal:  J Membr Biol       Date:  2021-07-23       Impact factor: 1.843
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.